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Abstract
Infection with Helicobacter pylori is responsible for gastritis and gastroduodenal ulcers but is also a high risk factor for the
development of gastric adenocarcinoma and lymphoma. The most pathogenic H. pylori strains (i.e., the so-called type I
strains) associate the CagA virulence protein with an active VacA cytotoxin but the rationale for this association is unknown.
CagA, directly injected by the bacterium into colonized epithelium via a type IV secretion system, leads to cellular
morphological, anti-apoptotic and proinflammatory effects responsible in the long-term (years or decades) for ulcer and
cancer. VacA, via pinocytosis and intracellular trafficking, induces epithelial cell apoptosis and vacuolation. Using human
gastric epithelial cells in culture transfected with cDNA encoding for either the wild-type 38 kDa C-terminal signaling
domain of CagA or its non-tyrosine-phosphorylatable mutant form, we found that, depending on tyrosine-phosphorylation
by host kinases, CagA inhibited VacA-induced apoptosis by two complementary mechanisms. Tyrosine-phosphorylated
CagA prevented pinocytosed VacA to reach its target intracellular compartments. Unphosphorylated CagA triggered an
anti-apoptotic activity blocking VacA-induced apoptosis at the mitochondrial level without affecting the intracellular
trafficking of the toxin. Assaying the level of apoptosis of gastric epithelial cells infected with wild-type CagA
+/VacA
+ H.
pylori or isogenic mutants lacking of either CagA or VacA, we confirmed the results obtained in cells transfected with the
CagA C-ter constructions showing that CagA antagonizes VacA-induced apoptosis. VacA toxin plays a role during H. pylori
stomach colonization. However, once bacteria have colonized the gastric niche, the apoptotic action of VacA might be
detrimental for the survival of H. pylori adherent to the mucosa. CagA association with VacA is thus a novel, highly ingenious
microbial strategy to locally protect its ecological niche against a bacterial virulence factor, with however detrimental
consequences for the human host.
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Introduction
Infection with Helicobacter pylori is responsible for gastritis and
gastroduodenal ulcers but is also a high risk factor for the
development of mucosa-associated lymphoid-like tissue (MALT)
lymphoma as well as gastric adenocarcinoma [1]. H. pylori strains
have been classified by the presence or the absence of two
virulence factors, namely: an active vacuolating toxin VacA [2]
and a 40-kbp pathogenicity island (cag PAI) encoding the 120–
145 kDa immunodominant protein termed cytotoxin-associated
gene A (CagA) as well as a type IV secretion system (TFSS) that
injects CagA into the host cell [3]. Type I strains produce an active
VacA and contain the cag PAI whereas type II synthesize an
inactive VacA, due to mutations in the cytotoxin gene, and lack
the cag PAI. H. pylori type I is responsible for the most severe
pathogenic effects of the bacterium whereas type II induces mild
gastritis only [4]. The CagA protein is probably the pivotal
bacterial determinant for the development of a severe gastric
inflammation that favors, in the long-term (years or decades), the
occurrence of ulcer and cancer [5]. Albeit the VacA cytotoxin was
first described as provoking cell vacuolation [6], it also induces
apoptosis of gastric epithelial cells via the mitochondrial pathway
(i.e., the so-called intrinsic pathway) [7–10]. As suggested [11],
VacA may play a role in the early steps of bacterial gastric
colonization.
Different host cell signaling cascades are activated by CagA
[3,12]. Importantly, different effects have been observed depend-
ing on the occurrence of phosphorylation by the Src kinase family
PLoS Pathogens | www.plospathogens.org 1 October 2009 | Volume 5 | Issue 10 | e1000603(SKF) of tyrosine residues contained within EPIYA motifs located
in the C-terminal 35–45 kDa part of CagA [3,12]. A well-
established response elicited by the phosphorylated form of CagA
is a morphological process consisting in the formation of an
elongated cell phenotype termed ‘‘hummingbird’’ [13]. This effect
is mainly due to deactivation of the SKF by the tyrosine-
phosphorylated CagA acting in fine on actin-binding proteins and
producing a rearrangement of the actin cytoskeleton [14,15]. In
the unphosphorylated form, CagA stimulates the Erk1/2 pathway
via its association with Grb2 [16] leading to a proinflammatory IL-
8 response by activating the NF-kB pathway [17] and, as recently
reported, antagonizing apoptosis of gastric cells at the level of the
intrinsic pathway [18]. Quite recently, it has been reported that
the phosphorylation-independent proinflammatory and anti-apo-
ptotic activities of CagA could be accounted for by a C-terminal
domain of CagA distinct from the EPIYA motif and named
CRPIA (conserved repeat responsible for phosphorylation-inde-
pendent activity) [19].
In the present study, we therefore examined whether CagA
might be able to counteract the apoptotic effect of VacA. Here we
demonstrate that, depending on tyrosine-phosphorylation by host
kinases, CagA inhibited VacA-induced apoptosis by two comple-
mentary mechanisms. Tyrosine-phosphorylated CagA prevented
pinocytosed VacA to reach intracellular compartments, a
prerequisite for VacA-induced apoptosis. Unphosphorylated
CagA triggered an anti-apoptotic activity blocking VacA-induced
apoptosis at the mitochondrial level without affecting the
intracellular trafficking of the toxin.
Results
The C-terminal signaling domain of CagA can mimick the
phosphorylation-dependent and -independent activities
of the full-length protein
To dissect the possible molecular mechanisms by which CagA
might interfere with VacA-induced apoptosis, we constructed
fusion molecules with the GFP protein encompassing or not the
38 kDa C-terminal signaling domain of CagA at the C-terminus of
GFP (GFP-CagA C-ter wt) (Figure S1A). The 38 kDa C-terminal
part of the CagA from H. pylori strain 26695 [20] contains 2
consensus EPIYA motifs (named A and C, respectively) that may
be tyrosine-phosphorylated by SKF [21]. In the present study we
used only the C-terminal signaling part of CagA since, while the
100 kDa N-terminal domain of the protein is important for
determining its intracellular localization, the CagA C-terminal
domain is normally phosphorylated by SKF and fully able to
reproduce the effects of phosphorylated full-length CagA inde-
pendently of the presence of the N-terminal domain [22]. We
reasoned that by preventing EPIYA phosphorylation through site-
directed mutagenesis of its tyrosine residues we would preserve
only the phosphorylation-independent effects of CagA. We thus
mutated the tyrosine residues contained within the two EPIYA
motifs into glycine (GFP-CagA C-ter mut) (Figure S1A). Then, we
tested the effects of the wt and mut constructions in human gastric
epithelial AGS cells. Upon transfection of these DNA constructs
into cultured AGS cells, the resulting proteins were expressed at
their expected molecular sizes. They reacted with both the anti-
GFP and anti-CagA antibodies and exhibited a roughly similar
repartition between membrane and cytosolic fractions (Figure
S1B). The GFP-CagA C-ter was associated almost equally
between the membrane and cytosolic fractions (differently from
the GFP molecule alone that was mainly cytosolic) (Figure S1B).
This is in agreement with the observation that a single EPIYA
motif favors the recruitment of CagA to the plasma membrane,
independently of its tyrosine phosphorylation [23]. As expected,
the GFP-CagA C-ter wt was tyrosine-phosphorylated whereas the
mutated form was not (Figure S1C). As previously shown [13,22],
the CagA C-ter wt greatly increased the number of cells showing
the characteristic elongated hummingbird phenotype (Figure 1A),
due to deactivation of SKF by the tyrosine-phosphorylated CagA
[14,15]. This effect was not observed in cells transfected with the
GFP-CagA C-ter mut, albeit the fusion protein was expressed at a
same level than the wt form in the cytosol (Figure 1A). In AGS
cells transfected with the GFP-CagA C-ter wt, only a slight
increase in the basal level of NF-kB p65-Rel nuclear translocation
(Figure 1B) and no IL-8 chemokine response were observed
(Figure 1C). This is in agreement with the previous finding that the
CagA C-ter domain does not fully reproduce the phosphorylation-
independent effects of the full-length CagA [22]. Conversely, when
the GFP-CagA C-ter mut was transfected into cells, a massive
translocation of NF-kB p65-Rel into the nucleus (Figure 1B) and a
robust IL-8 response were observed (Figure 1C), as reported
previously for CagA injected into gastric cells by the H. pylori TFSS
[15]. This result validated the use of the GFP-CagA-C-ter mut
construct to obtain the cell effects of CagA independent of its
phosphorylation. Finally, we tested whether our CagA C-ter
constructs were able to decrease the activation of the c-Src kinase
as previously reported for CagA [14]. In AGS cells transfected
with either the wt or the mut form of CagA C-ter, we measured
the phosphorylation level of the tyrosine 416 of c-Src. Indeed,
tyrosine 416 phosphorylation is required for the activation of the
Src kinase [24,25]. As shown in Figure 1D, transfection with GFP-
CagA C-ter wt caused a profound decrease in c-Src tyrosine 416
phosphorylation, while the mut form was only slightly effective.
This confirms that inhibition of the SKF by CagA is specifically
induced by the phosphorylated form of CagA [14].
Altogether, these results show that in a tyrosine-phosphorylated
form, the signaling domain of CagA produces the characteristic
morphological cell effects and inhibition of SKF activity whereas
in an unphosphorylated form it activates proinflammatory
responses. This demonstrated that, upon transfection into gastric
epithelial cells, the GFP-CagA C-ter constructions can separately
mimick the reported effects of the full-length CagA molecule
injected into cells by H. pylori TFSS [3,12,26]. Interestingly, CagA
has been shown to induce an anti-apoptotic activity [18,27]
Author Summary
The gram-negative bacterium Helicobacter pylori is the
main causative agent of peptic ulcer and gastric cancer in
humans. Our work sheds light on a new molecular
mechanism by which H. pylori would exert its highly
efficient colonization strategy of the human host. In this
paper, we show that the H. pylori CagA protein counter-
acts, by two distinct non-overlapping mechanisms, the
apoptotic activity of the H. pylori VacA toxin on human
gastric epithelial cells so as to allow a protection of the
bacterium niche against VacA, giving a rationale for the
association of these two virulence factors in the most
pathogenic H. pylori strains. This is a new, highly ingenious
mechanism by which a bacterium locally protects its
ecological niche against the action of one of its own
virulence factors. However, while exerting a beneficial role
for survival and growth of the bacterium by counteracting
VacA toxin, CagA injection in the gastric epithelial cells
triggers proinflammatory and anti-apoptotic responses
which are detrimental for the human host in the long-term
and favor the development of ulcer and cancer.
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PLoS Pathogens | www.plospathogens.org 2 October 2009 | Volume 5 | Issue 10 | e1000603Figure 1. Effects of the GFP-CagA C-ter fusion proteins expressed into gastric epithelial cells. (A) Fluorescence of AGS cells transfected
with GFP or GFP-CagA C-ter, either wt or mut. Transfected cells (green), actin staining (red). All the pictures shown represent single confocal sections.
Scale bar: 10 mm. The graph: percentage of cells exhibiting the so-called ‘‘hummingbird phenotype’’ for each transfection condition. Mean6SEM by
extensive confocal microscopy evaluation of slides from 3 independent experiments. *: P,0.05 versus non-transfected cells. (B) AGS cells transfected
with GFP or GFP-CagAC-ter, either wt or mut, and then quantitatively analyzed for NF-kB p65-Rel nuclear translocation. Mean6SEM of 3 independent
experiments. *: P,0.05 versus non-transfected cells. u: P,0.05 versus GFP-CagA C-ter wt. (C) AGS cells transfected with GFP or GFP-CagA C-ter, either
wt or mut. After 24 h the cell culture supernatants were tested for IL-8. Mean6SEM of 3 independent experiments. *: P,0.05 versus non-transfected
cells. (D) Representative blot (top) showing expression of c-Src, either total or activated form (c-Src P-Tyr 416; i.e., exhibiting tyrosine 416
phosphorylation) in AGS cells transfected with GFP or GFP-CagA C-ter, either wt or mut. Histograms (bottom) represent the quantitation of c-Src P-Tyr
416 (normalized for protein loading (a-tubulin) and shown as percentage of GFP-transfected control cells) for each transfection condition.
Mean6SEM of 3 independent experiments. *: P,0.05 versus GFP. u: P,0.05 versus GFP-CagA C-ter wt. (E) Apoptosis (shown as fold increase over the
non-transfected control cells) induced by 3 h treatment with 0.5 mM staurosporine in AGS cells transfected with GFP or GFP-CagA C-ter, either wt or
mut. Mean6SEM of 3 independent experiments. *: P,0.05 versus paired control. u: P,0.05 versus all other staurosporine-treated conditions.
doi:10.1371/journal.ppat.1000603.g001
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on the mitochondrial pathway) recently shown to be antagonized
by CagA in a phosphorylation-independent fashion [18]. This fact
raised the possibility that our CagA C-ter constructs might
differently affect cell apoptosis. We thus next tested whether the
GFP-CagA C-ter constructs might affect the mitochondrial
apoptotic pathway antagonizing, for instance, the cell death
induced by staurosporine, a drug specifically triggering the
intrinsic cell death pathway [28]. As shown in Figure 1E, only
the mut form of the GFP-CagA C-ter construct was able to down-
modulate staurosporine-induced apoptosis.
CagA, either tyrosine-phosphorylated or not, counteracts
the apoptotic activity of VacA
We then investigated whether transfection of human gastric
epithelial cells with either the wt or the mut forms of the GFP-
CagA C-ter was able to antagonize the apoptotic activity induced
by either the VacA cytotoxin or the drug etoposide. When non-
transfected AGS or MKN 28 cells were treated with purified
VacA, a statistically significant cell apoptosis was observed
(Figure 2A). As expected, etoposide was also inducing a statistically
significant apoptotic effect in both gastric cell lines (Figure 2A). In
cells transfected with the GFP-CagA C-ter wt, the VacA-induced
apoptotic effect was inhibited (Figure 2A). However, this CagA
construction did not impair the apoptotic effect induced by
etoposide (Figure 2A). In cells transfected with the GFP-CagA C-
ter mut, the apoptotic effects induced by either VacA or etoposide
were both inhibited (Figure 2A). Our results thus suggest that
CagA may counteract VacA apoptotic activity by acting at two
different molecular levels, one of which was clearly ineffective for
etoposide. A possibility was that, in one hand, CagA might alter
the effect of VacA by impairing the specific pinocytosis and/or
intracellular trafficking of the cytotoxin [29,30]. This mechanism
would be clearly ineffective for etoposide that penetrates into cells
by simple diffusion. On the other hand, the apoptotic activity of
both VacA and etoposide might be antagonized by upregulation of
anti-apoptotic factors since the two molecules act finally on the
intrinsic cell death pathway.
Tyrosine-phosphorylated CagA blocks the trafficking of
VacA toward its target intracellular compartments
When the GFP-CagA C-ter wt was transfected into human
gastric epithelial cells and then challenged with purified VacA,
virtually no VacA was able to deeply penetrate inside the cells
reaching intracellular compartments such as late endosomes
(LEs; LAMP1-positive compartment) (Figure S2) and no
vacuolation was observed in transfected cells compared to
GFP-transfected or non-transfected control cells (Figure 2B and
C). Clearly most of the toxin remained associated in the inner cell
periphery, likely in the GPI-anchored-protein-enriched-early-
endosomal-compartments (GEECs) (Figure S2 and zooms of
Figure 2B and C), as we have previously shown [30]. This
indicated that, after binding to its membrane receptor sphingo-
myelin [31], pinocytosis of VacA was not inhibited but the
further intracellular trafficking of the cytotoxin was blocked. On
the other hand, when cells were transfected with the GFP-CagA
C-ter mut (whose cell expression pattern/localization was
virtually identical to that of the wt form), both VacA in LEs
and large vacuoles were easily observed, as in GFP-transfected or
non-transfected cells (Figures S2 and 2B and C). Molecules
pinocytosed into GEECs are transferred to early endosomes
(EEs) [30]. We have previously shown that comet-like F-actin
structures associated at the tip of EEs were required to sort out
VacA from GEECs so as to transport the cytotoxin to LEs [32].
We made the hypothesis that also VacA-induced apoptosis could
be provoked by the transport, mediated by F-actin motility of
endosomes, of the toxin either directly to mitochondria [32] or to
a specific intracellular compartment from which the toxin is then
delivered into the cytosol to indirectly trigger the intrinsic cell
death pathway as suggested [10]. We have shown that treatment
of cells that have already pinocytosed VacA into GEECs (after
30 min of pinocytosis) with cytochalasin D (CD) prevented the
cytotoxin to reach LEs, as shown by the inhibition of the
vacuolation effect of VacA and the lack of colocalization of the
cytotoxin with the late endosomal marker LAMP1 [32]. If VacA
requires the same mechanism (i.e., actin-based motility of VacA-
containing endosomes) to be transferredto mitochondria where it
causes apoptosis, it should be pos s i b l et ob l o c kt h et r a n s f e ro ft h e
cytotoxin to mitochondria and the following apoptosis by
depolymerization of F-actin. Moreover, modification of the
mitochondrial transmembrane potential (MTP) is an early event
in VacA-induced apoptosis (contemporary to cell vacuolation)
[33]. A mechanism likely provoked by the transfer of only very
few toxin molecules into mitochondria [7,34]. Using the same
experimental approach previously described for CD-induced
inhibition of VacA-induced vacuolation [32], we tested whether
disruption of F-actin could affect the decrease in MTP and cell
apoptosis induced by VacA as well as its trafficking to
mitochondria. Using the ratiometric potential-sensitive dye JC-
1t oe v a l u a t et h er e l a t i v eM T P ,w ef o u n dt h a tC Dt r e a t m e n t
protected the gastric epithelial cells by VacA-induced decrease in
MTP (Figure 3A). When DsRed-Mito-transfected cells were
e x p o s e dt oC y 5 - V a c Ai nt h ea b s e n c eo fC Dt r e a t m e n t ,w ef o u n d
that mitochondria lost their typical spaghetti-like morphology
(which is becoming a bona fide marker for mitochodrial integrity
[35,36]) and showed some VacA molecules inside (Figure 3B).
On the contrary, CD treatment was able to prevent both VacA-
induced alteration in mitochondrial morphology and any
colocalization of the toxin with mitochondria (Figure 3B).
Furthermore, CD treatment caused a statistically significant
decrease in VacA-induced apoptosis (Figure 3C). What might be
the molecular mechanism by which CagA C-ter wt could block
the trafficking of VacA-containing endosomes? It was recently
shown that the Src-like kinase p61HcK was required to build
comet-like F-actin structures at the tip of lysosomes [37] and
tyrosine-phosphorylated CagA as been reported to inhibit the
activation of the SKF [14,15]. Accordingly, we found that cell
transfection with the CagA C-ter wt construct caused a blockage
of the phosphorylation level of the tyrosine 416 of c-Src
(Figure 1D), which is essential for SKF kinase activity [25].
Using the specific SKF inhibitor PP2, we thus investigated
whether deactivation of SKF could block the exit of the cytotoxin
from GEECs by inhibiting the retrieval of VacA-loaded EEs from
these compartments. Inhibition of the SKF in AGS or MKN 28
cells by PP2 considerably decreased the cytotoxin exit from
GEECs to intracellular compartments such as LEs (LAMP1-
positive compartment) (Figure 4A and B), as observed in GFP-
CagA-C-ter wt transfected cells (zooms of Figure 3B and C).
Furthermore, PP2 significantly decreased VacA-induced apo-
ptosis (Figure 4C). On the contrary, PP2 was without any effect
on etoposide-induced apoptosis (Figure 4C). These results
highlighted the role of the SKF in the control of a specific step
of VacA intracellular trafficking (i.e., its exit from GEECs)
suggesting that one role of CagA (in its phosphorylated form)
is to block, via SKF inhibition, the progression of pinocytosed
VacA toward its target intracellular compartments (LEs and
mitochondria).
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PLoS Pathogens | www.plospathogens.org 4 October 2009 | Volume 5 | Issue 10 | e1000603Figure 2. Transfection of gastric epithelial cells with GFP-CagA C-ter, either wt or mut, antagonizes VacA-induced apoptosis. (A)
Apoptosis (shown as fold increase over the respective non-transfected control cells) induced by either VacA or etoposide in gastric AGS or MKN 28
cells. VacA was used at 5 mg/ml for 18 h, while etoposide at 300 mM for 6 h (AGS cells) or 24 h (MKN 28 cells). Mean6SEM of 3 independent
experiments. *: P,0.05 versus paired control. (B and C) VacA internalization and its vacuolating action in transfected AGS (B) or MKN 28 (C) cells.
VacA (red) and nuclei (blue). Transfected cells (green). All the pictures shown represent single confocal sections. Scale bar: 10 mm. For a more careful
evaluation of VacA internalization, for each merged picture the overall z-stack profile of the cells along the depicted x-y axes were highlighted. (a),
(b), and (c) are respectively zooms of the merged pictures at each x-y intersection. The graph (top right): percentage of either vacuolated cells (white
columns) or cells deeply internalizing VacA (black columns) for each transfection condition. *: P,0.05 versus non-transfected cells. u: P,0.05 versus
GFP-CagA C-ter mut.
doi:10.1371/journal.ppat.1000603.g002
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PLoS Pathogens | www.plospathogens.org 5 October 2009 | Volume 5 | Issue 10 | e1000603Figure 3. Cytochalasin D treatment protects gastric epithelial cells against both drop in mitochondrial transmembrane potential
and apoptosis induced by VacA by preventing its mitochondrial localization. (A) Effect of cytochalasin D (CD) on mitochondrial
transmembrane potential (MTP) of MKN 28 cells, treated or not with VacA, evaluated by using the ratiometric potential-sensitive dye JC-1 and
confocal microscopy. All the pictures shown represent single confocal sections. Scale bar: 10 mm. The graph (right) shows the quantitation
(mean6SEM) of relative MTP in the different experimental conditions by extensive confocal microscopy evaluation of slides from 3 independent
experiments. *: P,0.05 versus paired control. u: P,0.05 versus the same condition in the presence of CD. (B) Morphology of mitochondria and their
colocalization with VacA in AGS cells transfected with DsRed-Mito and treated or not with Cy5-labelled VacA in the absence or presence of CD.
DsRed-Mito (red) and Cy5-VacA (green). All the pictures shown represent single confocal sections. Scale bar: 10 mm. (C) Apoptosis (shown as fold
increase over the CD-untreated control cells) induced by VacA in MKN 28 cells treated or not with CD. Cells treated or not with CD but not exposed to
VacA served as controls. Mean6SEM of three different experiments. *: P,0.05 versus paired control. u: P,0.05 versus the same condition in the
presence of CD.
doi:10.1371/journal.ppat.1000603.g003
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PLoS Pathogens | www.plospathogens.org 6 October 2009 | Volume 5 | Issue 10 | e1000603Figure 4. Treatment of gastric epithelial cells with the specific SKF inhibitor PP2 impairs the arrival of VacA into endosomes. (A and
B) VacA intracellular trafficking in AGS (A) or MKN 28 (B) cells treated or not with PP2. Cells were preincubated for 30 min at 37uC in the presence or
absence of 10 mM PP2 and, after a VacA binding step of 1 h at 4uC, immediately fixed (0 min) or allowed to internalize the toxin into early (30 min) or
late (120 min) endocytic compartments (top left panels). VacA in green. For the 120 min time point, also LAMP1 (red; a marker of late endosomes)
and its colocalization with VacA are shown (top right panels). All the pictures represent single confocal sections. Scale bar: 10 mm. The graphs
(bottom panels): effect of PP2 treatment on either the percentage of cells exhibiting VacA confined in the GEECs (left) or the percentage of late
endosomes (i.e., LAMP1-positive vesicles) containing VacA (right) after 2 h internalization. Mean6SEM by extensive confocal microscopy evaluation
of slides from 3 independent experiments. *: P,0.05 versus PP2-untreated cells. (C) Apoptosis (shown as fold increase over the respective PP2-
untreated control cells) induced by either VacA or etoposide in MKN 28 cells treated or not with PP2. Cells treated or not with PP2 but not exposed to
VacA or etoposide served as controls. Mean6SEM of three different experiments. *: P,0.05 versus paired control. u: P,0.05 versus the same
condition in the absence of PP2. The high cytotoxicity induced by PP2 on AGS cells after the incubation time used to measure either VacA- or
etoposide-induced apoptosis did not enable us to repeat the same set of experiments in this latter cell line.
doi:10.1371/journal.ppat.1000603.g004
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PLoS Pathogens | www.plospathogens.org 7 October 2009 | Volume 5 | Issue 10 | e1000603Unphosphorylated CagA does not increase the cell levels
of Bcl2, Bcl-xL or Mcl1 although its anti-apoptotic action
is completely mimicked by Bcl2 overexpression
The second role of CagA (in its unphosphorylated form) consists
in triggering an anti-apoptotic activity able to inhibit apoptosis
induced not only by VacA but also by staurosporine (Figure 1E)
and etoposide (Figure 2A). It has been shown that CagA may up-
regulate the expression of anti-apoptotic factors of the Bcl2 family
such as Bcl2 [27] or Mcl1 [18]. By transfecting gastric epithelial
cells with plasmids encoding for GFP-Bcl2, GFP-Bcl-xL or GFP-
Mcl1, we therefore tested the effects of these three different anti-
apoptotic factors of Bcl2 family in the protection of VacA- or
etoposide-induced apoptosis. We found that cells transfected with
the GFP-Bcl2 construct were highly resistant to the apoptotic
action of either the cytotoxin or etoposide (Figure 5A). This finding
well fits with our previous demonstration that Bcl2 antagonized
the apoptotic activity of VacA when the toxin was expressed into
cells [7]. On the other hand, cells transfected with the GFP-Bcl-xL
construct were not protected against the apoptotic effect of VacA
whereas the cell death provoked by etoposide was blocked
(Figure 5A). It is worth noting that either Bcl2 or Bcl-xL
expression did not interfere with VacA endocytosis in AGS or
MKN 28 cells as evaluated by confocal microscopy (Figure 5B and
C). Finally, the GFP-Mcl1 construct induced a significant (even
though partial) protection against VacA-induced apoptosis in AGS
cells as well as in MKN 28 cells (Fig. 5A). In both cell lines tested
GFP-Mcl1 overexpression afforded also a protective action
(complete in AGS while only partial in MKN28 cells) against
etoposide-induced apoptosis (Figure 5A). We thus tested whether
the GFP-CagA C-ter wt or mut could induce an up- or down-
regulation of these anti-apoptotic factors. However, we were
unable to find a statistically significant increase or decrease in the
expression of these factors by either the wt or mut form of the
CagA C-ter (Figure S3).
Infection of gastric epithelial cells with CagA-defective H.
pylori confirms that CagA counteracts the apoptotic
activity of VacA
To confirm the results obtained in cells transfected with the
CagA C-ter constructions showing that CagA antagonizes VacA-
induced apoptosis, we finally measured the level of apoptosis of
gastric epithelial cells infected with wild-type CagA
+/VacA
+ H.
pylori or isogenic mutants lacking of either CagA or VacA. MKN
28 cells infected with the wild-type CagA
+/VacA
+ 60190 H. pylori
strain showed an apoptosis degree slightly higher (even though not
statistically significant) than that observed in non-infected control
cells and virtually identical to that induced by its VacA-defective
isogenic mutant (Figure 6). On the contrary, upon infection with
the CagA-defective isogenic mutant, we observed an amount of
cell apoptosis significantly higher than that caused by either the
wild-type or the VacA-defective strain (Figure 6). The stronger
apoptotic action exerted by the CagA-defective strain in
comparison to its parental strain appeared completely due to its
VacA production since, when infection of MKN 28 cells with H.
pylori was carried out in the presence of an excess of the dominant-
negative purified VacA D6-27 mutant cytotoxin [8,38], we found
an apoptosis level virtually identical for all the three strains tested
(i.e., the wild-type and its isogenic mutants lacking CagA or VacA,
respectively) (Figure 6). Indeed, VacA D6-27 is a well-known
mutant toxin that not only lacks any vacuolating and apoptotic
activity by itself but also, when mixed with wild-type VacA,
specifically inhibits both cell vacuolation and apoptosis induced by
the wild-type toxin [8,38]. The anti-apoptotic activity of CagA in
H. pylori-infected MKN 28 cells was further verified using another
wild-type CagA
+/VacA
+ strain (i.e., G27) and its CagA-defective
isogenic mutant (Figure S4). By using these latter H. pylori strains,
the anti-apoptotic activity of CagA was also confirmed in H. pylori-
infected AGS cells where, in agreement with previous findings [8],
the wild-type CagA
+/VacA
+ strain was however causing a
significantly higher degree of apoptosis in comparison to non-
infected control cells (Figure S4).
Discussion
In the present study we have shown that injection of the CagA
protein by TFSS into gastric epithelial cells induced a protection
against the apoptotic effects of the VacA cytotoxin. Importantly,
depending on the tyrosine phosphorylation state of CagA, two
separate mechanisms of protection were unraveled. However,
because of the multifunctional activities of CagA [3,12,26], we
cannot exclude that others CagA-triggered cell signaling pathways
might be also involved in the protection against VacA-induced
apoptosis. Indeed, mounting evidence suggests the existence of a
substantial cross-talk between CagA and VacA in H. pylori-infected
gastric epithelial cells. VacA might inhibit the activation of the
transcription factor NFAT induced by CagA [39] or the cell
scattering and elongation activities of CagA [40] which in turn
might decrease the vacuolation induced by VacA [41]. Thus CagA
and VacA appears to counteract their respective activities on host
cells.
To study the possible activities of CagA on VacA-induced
apoptosis, the experimental approach we used was based on i) cell
transfection assays involving the expression of the C-terminal
domain of the CagA protein that can be (GFP-CagA C-ter wt) or
not (GFP-CagA C-ter mut) tyrosine phosphorylated by cellular
SKF and ii) direct cell infection assays by wild-type Helicobacter
pylori or its isogenic mutants defective in CagA or VacA. For
transfection experiments, we used the C-terminal domain of CagA
since it contains the essential signaling motifs that modulate the
activities of the protein [19,42,43] and already shown to induce
the effects of CagA [22]. Cell transfection experiments allowed us
to dissect, at the molecular level, possible signaling pathways by
which CagA affords protection against VacA-induced apoptosis.
In a first set of experiments, we validated our GFP-CagA C-ter
cell transfection assays by showing that the signaling 38 kDa C-
terminal domain of CagA containing the EPIYA motifs was
indeed responsible for the important effects of CagA on host cells
as previously reported by several groups [19,22,42,43]. For
instance, cell elongation (i.e., the hummingbird phenotype)
[13,42,44,45] is strictly phosphorylation-dependent whereas
activation of NF-kB, production of IL-8 and protection against
apoptosis are CagA activities independent of its tyrosine
phosphorylation [16–19].
In cells transfected with the GFP-CagA C-ter wt, most of the
VacA molecules were unable to deeply penetrate inside the cells
but remained confined immediately under the plasma membrane,
likely in GEEC compartments we have described previously [30].
This indicated that the first step of VacA endocytosis (namely
pinocytosis) [30] was not affected by CagA. To leave GEECs and
be able to traffick to internal cell compartments (i.e., LEs and
mitochondria), vesicles containing VacA must be associated with
dynamic actin structures [32]. We have previously shown that
dynamic F-actin structures associated at the tips of EEs were
required to sort VacA from GEECs to intracellular compartments
[32], probably to retrieve VacA-loaded EEs out of GEECs and to
allow trafficking to LEs [32]. Association of dynamic actin
structures with EEs, required for the trafficking of ligands from
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PLoS Pathogens | www.plospathogens.org 8 October 2009 | Volume 5 | Issue 10 | e1000603Figure 5. Transfection of gastric epithelial cells with GFP-Bcl2 inhibits VacA-induced apoptosis while not blocking pinocytosis or
intracellular trafficking of the toxin. (A) Apoptosis (shown as fold increase over the respective non-transfected control cells) induced by either
VacA or etoposide in AGS or MKN 28 cells transfected with GFP-Bcl2, GFP-Bcl-xL, GFP-Mcl1, or the GFP vector. Cells were treated with VacA or
etoposide as in Figure 3A. Non-treated cells served as controls. Mean6SEM of 3 independent experiments. *: P,0.05 versus paired control. (B and C)
VacA internalization in AGS (B) or MKN 28 (C) cells transfected with GFP-Bcl2, GFP-Bcl-xL, or the GFP vector. VacA (red) and nuclei (blue). Transfected
cells (green). All the pictures shown represent single confocal sections. Scale bar: 10 mm. For a more careful evaluation of VacA internalization, in
every merged picture the overall z-stack profile of the cells along the depicted x-y axes were highlighted. (a), (b), and (c) are respectively zooms of
the merged pictures at each x-y intersection.
doi:10.1371/journal.ppat.1000603.g005
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formation of these dynamic actin structures are dependent upon
the tyrosine phosphorylation of annexin 2 [47]. CagA wt decreases
the tyrosine kinase activity of SKF ([14,15], this study). Likely, the
drop of SKF activity by the phosphorylated form of CagA blocked
a critical step necessary for the motility of VacA-containing
compartments to reach its intracellular targets. Using the pan SKF
inhibitor PP2 we have shown that, as for the transfection of cells
with the GFP-CagA C-ter wt, PP2 blocked the exit of VacA-
containing vesicles from GEECs resulting in protection against
apoptosis induced by the toxin. These findings indicated that
VacA trafficking from GEECs to intracellular targets is controlled
by SKF. Restriction of VacA to GEECs, by treatment with CD
after the first step of cytotoxin endocytosis, not only decreased the
cell vacuolation [32] but also both MTP drop and apoptosis
induced by VacA (this study).
One study hypothesized that VacA may act only indirectly on
mitochondria to release cytochrome c taking that i) isolated
mitochondria incubated with VacA had a drop in the MTP but
apparently no release of cytochrome c, and ii) in cells incubated
with VacA the cytosolic proapoptotic factor Bax was activated
while no colocalization between mitochondria and the toxin was
found [10]. This result was challenged by the demonstration that
isolated mitochondria incubated with VacA release a small but
statistically significant amount of cytochrome c [48]. VacA or its
p37 N-terminal domain are able to directly enter isolated
mitochondria and to localize into the mitochondrial matrix/inner
membrane and to induce apoptosis [7,9,34,49]. Therefore, our
findings suggest that, as in the case of other potent bacterial toxins
acting intracellularly [50], only a small proportion of pinocytosed
VacA reach its final target (i.e., mitochondria) albeit a large
amount of the cytotoxin is routed to LEs.
For either the direct or indirect activation of the cell death
intrinsic pathway, cytochrome c release by mitochondria requires
the permeabilization of the mitochondrial outer membrane
(MOM) by oligomerization of proapoptotic proteins of the Bcl2
family (Bax and Bak) [51,52]. Thus it is not surprising to observe
activation of Bax (or Bak) during that process [10]. Importantly, a
direct activity of VacA on mitochondria for toxin-induced cell
death is supported by the observation that mutations of the N-
terminal p37 domain of VacA which blocks the transfer of the
toxin into mitochondria also impairs VacA-induced apoptosis [7].
Therefore, a possible mechanism for VacA-induced mitochondrial
damage could be the following: via endosomes propelled by actin
polymerization, VacA is transferred to mitochondria (either
directly by membrane-to-membrane contacts or after release into
the cytosol followed by importation into mitochondria) where full-
length VacA or its p37 N-terminal domain translocates to the
mitochondrial inner membrane (MIM)/matrix of the organelle
[7,9]. There, VacA (or its N-terminal p37 domain) induces MIM
depolarization, for instance by making a channel in the MIM as
proposed recently [9,34]. This activity might disrupt mitochon-
drial cristae junctions by interfering with the MIM OPA1 protein
or molecules interfering with the control of OPA1, a critical step of
cytochrome c release [53]. This may allow the release of large
quantities of cytochrome c in the intermembrane mitochondrial
space and, due to a small leakage of the MOM (which is not a fully
impermeable membrane), a small amount of cytochrome c could
be released out of mitochondria as observed in vitro [48]. This
small release of cytochrome c might be able by itself to trigger the
activation of a minute amount of caspase 3. Since caspase 3 has
been reported to induce Bax translocation to MOM amplifying
the release of cytochrome c [54], the initial direct effect of VacA on
MIM would be followed by a massive, Bax-dependent, release of
cytochrome c.
We have shown that in its unphosphorylated form CagA was
able to induce an anti-apoptotic response not only toward
staurosporine or etoposide as already described [18,19], but also
against VacA. The Bcl2 anti-apoptotic factor, but not the Bcl-xL
or Mcl1 factors, has been reported to be upregulated by CagA
[27]. More recently, the anti-apoptotic factor Mcl1 has been
shown to be upregulated, through activation of the NF-kB
pathway, specifically by the unphosphorylated form of CagA
[18,19]. In the present study we have been unable to demonstrate
that the C-ter domain of CagA might significantly up- or down-
regulate Bcl2, Bcl-xL or Mcl1. Nevertheless, overexpression of
Bcl2 and, although to a lesser extent, Mcl1 clearly afforded a
protection against VacA-induced apoptosis in both AGS and
MKN28 cells mimicking the action of unphosphorylated CagA.
Interestingly, it has been quite recently reported that, in
nonmyeloid cells, Shigella flexneri was able to induce mitochondri-
al-dependent cell death but, at the same time, the bacterium was
also triggering a prosurvival Nod1-dependent Rip2/IKKb/NF-kB
signaling pathway [55]. However, activation of the NF-kB
pathway was not acting by increasing the expression level of
Bcl2 family members, but rather preventing Bcl2 expression drop
during bacterial infection [55]. A similar effect might take place
during H. pylori infection and Bcl2 and Mcl1 might be the anti-
apoptotic factors involved in CagA action against VacA-induced
apoptosis.
It is well known that CagA is rapidly tyrosine phosphorylated
after its injection into host cells [3,12,26]. At difference,
production of IL-8 by the unphosphorylated form of CagA
appears to be a very late event (starting after 24 h of infection)
upon cell infection by H. pylori [17]. Therefore, the earliest
mechanism for CagA-dependent inhibition of VacA-induced
apoptosis would likely rely on the activity of the phosphorylated
form of CagA. Indeed, blocking the trafficking of VacA would be
an efficient mechanism for its neutralization. In agreement with
that possibility, it has been demonstrated that injection of CagA
into cells was strongly decreasing the vacuolating activity of the
toxin [41]. Vacuolation induced by VacA is an early event and
Figure 6. CagA antagonizes VacA-induced apoptosis in H.
pylori-infected MKN 28 gastric epithelial cells. Apoptosis degree
(shown as fold increase over the respective non-infected control cells)
of MKN 28 cells infected with the wild-type CagA
+/VacA
+ H. pylori strain
60190 (WT) or its isogenic mutants lacking CagA (DcagA) or VacA
(DvacA), respectively, in the absence or presence of 5 mg/ml dominant-
negative purified VacA D6-27 cytotoxin. Mean6SEM of 3 independent
experiments. *: P,0.05 versus paired control.
doi:10.1371/journal.ppat.1000603.g006
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study, we have shown that the phosphorylated form of CagA was
indeed blocking the trafficking of the pinocytosed VacA and
reduced the cell vacuolation induced by the cytotoxin. We have
here also shown that blocking the motility of VacA-containing
endosomes also decreased both MTP drop and apoptosis
provoked by VacA and, interestingly, abolished the colocalization
of the cytotoxin with mitochondria. These observations indicate
that both the trafficking to LEs and to mitochondria necessitates
an actin-driven vesicle activity [32]. However, even if the large
majority of pinocytosed VacA is prevented to reach its intracellular
targets by the protection pathway dependent on tyrosine-
phophorylated CagA, also a very small amount of cytotoxin
molecules reaching mitochondria could be enough to significantly
activate the intrinsic apoptotic pathway during the course of
infection. Apoptosis could be efficiently counteracted by activation
of the NF-kB pathway allowing the upregulation of anti-apoptotic
factor(s) (together with the production of IL-8). IL-8 production, a
bystander of the NF-kB activation triggered by unphosphorylated
CagA, is detectabled only after 24 h of infection [17]. This
suggests that this kind of CagA-dependent protection against
VacA-induced apoptosis is probably a later event during cell
infection by H. pylori. Thus the combination of an earlier event
(due to phosphorylated CagA), preventing most VacA molecules to
reach mitochondria (and LEs), with a later event (due to
unphosphorylated CagA), directly blocking the intrinsic apoptotic
pathway, would constitute a clever and highly efficient system for
protecting the cells against VacA-induced apoptosis.
Apparently, the VacA toxin plays a role during H. pylori stomach
colonization [11]. However, once bacteria have colonized the
gastric niche, the apoptotic action of VacA might be detrimental
for the survival of H. pylori adherent to the mucosa. By injecting
CagA into the colonized host cells, protection against VacA
apoptosis would be afforded with great efficiency. In addition, as
recently proposed, the anti-apoptotic activity of CagA might also
dampen epithelial gastric cell renewal [18] whereas VacA would
decrease the CagA-induced cell scattering and motility [40].
Interestingly, in this scenario the VacA toxin could still diffuse at
distance from the bacteria colonizing the surface gastric epithelium
to decrease, for instance, both the innate and adaptive immune
response of the host against H. pylori [56]. This might finally
explain the virtually constant association of an active VacA toxin
with CagA in highly pathogenic H. pylori strains. CagA association
with VacA is thus a novel, highly ingenious microbial strategy to
locally protect its ecological niche against a bacterial virulence
factor, with however detrimental consequences for the human
host. Indeed, by exerting proinflammatory and anti-apoptotic
activities, CagA favors, in the long-term, the occurrence of the
most severe gastric diseases such as peptic ulcer and gastric cancer.
Materials and Methods
Bacteria, VacA purification, human gastric epithelial cells,
antibodies, and reagents
The H. pylori strain 26695 [20] was a gift of R. Haas (Mu ¨nchen,
Germany). The wild-type CagA
+/VacA
+ H. pylori strain 60190
(ATCC 49503) and its isogenic mutants in which cagA (60190:M22)
or vacA (60190:v1) genes were disrupted by insertional mutagenesis
[57,58] were kindly provided by T.L. Cover (Nashville, TN). The
wild-typeCagA
+/VacA
+H.pyloristrainG27and itsisogenicmutant
(G27DcagA) in which cagA gene was disrupted by insertional
mutagenesis [59] were kindly provided by R. Zarrilli (Naples,
Italy). Bacteria were grown in Brucella broth medium (Difco,
Detroit, MI) supplemented with 1% Vitox (Oxoid, Basingstoke,
UK) and 5% heat-inactivated fetal bovine serum (FBS, from
Cambrex BioScience, Verviers, Belgium) at 37uC under micro-
aerobic conditions and continuous shaking [29].
VacA was purified from broth culture supernatant of wild-type
H. pylori 60190 strain by ammonium sulphate precipitation and gel
filtration chromatography using a Superose 6 10/300 GL column
(Amersham Biosciences, Umea, Sweden) in accordance with
Cover et al. [60] and its concentration was determined using the
DC protein assay kit (Bio-Rad, Hercules, CA). Purified VacA was
stored in melting ice and, immediately before use, was activated by
dropwise acidification to pH 3.0 with 0.2 N HCl [29,60]. For
some experiments, purified VacA labeled with Cy5 dye was
prepared and used as previously described [32]. The mutant VacA
toxin (VacA D6-27), lacking a critical hydrophobic region near the
VacA N-terminus and exhibiting a dominant-negative effect on
both cell vacuolation and apoptosis induced by wild-type VacA
[8,38], was a kind gift of T.L. Cover.
Human gastric epithelial AGS (ATCC CRL-1739) or MKN 28
cells [61,62] were grown in DMEM supplemented with 10% FBS
and 200 mM glutamine or in DMEM/Ham’s nutrient mixture F-
12 (1:1) (Sigma-Aldrich, St. Louis, MO) supplemented with 10%
FBS, respectively, at 37uC in a humidified atmosphere of 5% CO2
in air. Cell transfection with the plasmids used in this study was
carried out according to the manufacturer’s instructions using
FuGene6 (Roche Diagnostics, Mannheim, Germany) or Lipofec-
tamine (Invitrogen, Carlsbad, CA) for AGS cells and DOTAP
(Roche Diagnostics) for MKN 28 cells. For the experiments
assaying CagA-induced cell production of anti-apoptotic factors,
AGS cells were transfected by using the Amaxa electroporation
technology (Lonza, Walkersville, MD) in order to maximize
transfection efficiency.
The following primary antibodies were used: a) mouse
monoclonal anti-GFP (clone 7.1), from Roche; b) polyclonal
rabbit anti-CagA, kindly provided by A. Covacci (Siena, Italy); c)
mouse monoclonal anti-phosphotyrosine (clone 4G10), from
Euromedex (Souffelweyersheim, France); d) rabbit polyclonal
anti-VacA IgG 958, kindly given by T.L. Cover; e) mouse
monoclonal anti-LAMP1, from BD Biosciences (San Jose, CA); f)
rabbit polyclonal anti-p65-Rel, from Santa Cruz Biotechnology
(Santa Cruz, CA); g) mouse monoclonal anti-Bcl2 and rabbit
polyclonal anti-Bcl-xL and anti-Mcl1, all from Santa Cruz
Biotechnology; h) rabbit polyclonal against c-Src (from Santa
Cruz), and phosphospecific rabbit polyclonal against c-Src
phosphorylated at Tyr416 (Cell Signaling Technology, Danvers,
MA); i) mouse monoclonal anti-a-tubulin, from Sigma-Aldrich. As
secondary antibodies, we used: a) anti-mouse and anti-rabbit
conjugated to horseradish peroxidase (HRP), from Dako
(Glostrup, Denmark); b) anti-mouse labeled with Alexa 488 (from
Molecular Probes, Eugene, OR) or with aminomethylcoumarin
acetate (AMCA; from Jackson Immunoresearch, West Grove, PA);
c) anti-rabbit labeled with tetramethylrhodamine isothiocyanate
(TRITC) or Cy5, from Jackson Immunoresearch. TRITC-labeled
phalloidin and R-phycoerythrin-labeled (RPE) annexin V were
purchased from Molecular Probes. Nuclear counterstaining was
made with Hoechst 33258 (Sigma-Aldrich). The inhibitor of the
Src family tyrosine kinases 4-amino-5-(4-chlorophenyl)-7-(t-butyl)-
pyrazolo[3,4-d]pyrimidine (PP2) and the apoptosis-inducer etopo-
side were purchased from Biosource (Camarillo, CA) and Sigma-
Aldrich, respectively.
Construction of CagA fusion proteins and of site-directed
mutations
The cagA 39 region (940 bp), corresponding to the CagA protein
C-terminal domain of 38 kDa, containing the two tyrosine
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Chain Reaction (PCR) from the DNA of H. pylori 26695 strain
using the primers CagA C-ter wt 59 and CagA C-ter wt 39 (see
Table S1). The PCR product was cloned into the PCR2.1 vector
(TOPO Cloning Kit; from Invitrogen) according to the manufac-
turer’s instructions. The PCR product was then subjected to
BSRG1/Not1 cleavage and subcloned into a modified pEGFP-N1
vector (Clontech Laboratories, Mountain View, CA) to produce
fusion of CagA C-ter wild-type at the C-terminus of GFP (GFP-
CagA C-ter wt). Mutations of the tyrosine residues 899 and 972
into glycine to produce GFP-CagA C-ter mut were performed
using the QuikChange site-directed mutagenesis kit (Stratagene,
La Jolla, CA) according to the manufacturer’s instructions with the
oligonucleotides described in Table S1.
Immunoprecipitation, immunoblotting, cell fractionation,
actin staining, NF-kB nuclear translocation, IL-8
chemokine production, and expression of Bcl2, Bcl-xL,
and Mcl1
For immunoprecipitation of tyrosine-phosphorylated CagA C-
ter fusion proteins, transfected AGS cells were first washed twice
with a cold (4uC) ‘‘stop buffer’’ (20 mM Tris-HCl, pH 7.5,
containing 150 mM NaCl, 100 mM NaF, 2 mM Na3VO4,
10 mM Na4P2O7, 10 mM EDTA) and then scraped off from
the culture dish in lysis buffer (LB) (20 mM Tris-HCl, pH 7.4,
containing 150 mM NaCl, 100 mM NaF, 2 mM Na3VO4,
10 mM Na4P2O7, 10 mM EDTA, 1 mM okadaic acid, 1% Triton
X-100, and a protease inhibitor cocktail (Complete EDTA-free,
Roche)). Cells were then lysed in LB for 45 min at 4uC under
constant agitation. Cell lysates were centrifuged at 10,000 g for
5 min and protein concentration in the supernatant was measured.
Anti-phosphotyrosine antibodies were adsorbed on A/G sephar-
ose beads (Tebu-Bio, Le Perray en Yvelines, France) under
agitation and then added to 0.5 to 1 mg of cell supernatant
proteins. Tyrosine-phosphorylated proteins were immunoprecip-
itated for 3 h at 4uC under constant agitation. Immunoprecipi-
tated proteins were resuspended in a modified Laemmli buffer
(100 mM Tris-HCl, pH 6.8, 0.2% bromophenol blue, 20%
glycerol, 1.25% b-mercaptoethanol, and 4% SDS), resolved by
SDS-PAGE, immunoblotted and detected by incubation of the
membranes with anti-GFP or anti-CagA antibodies (dilution:
1:500) followed by incubation with either anti-mouse or anti-rabbit
HRP-conjugated antibodies. Immunoreactive bands were then
revealed by enhanced chemiluminescence reaction (ECL, Amer-
sham Biosciences). Cytosolic and membrane fractionation of
transfected AGS cells was performed essentially as described by
Stein et al. [63].
For actin staining and NF-kB nuclear translocation, variously
transfected AGS cells grown on coverslip were incubated for 18 h,
then fixed in 4% paraformaldehyde and permeabilized with 0.5%
Triton X-100 in PBS. After washing, cells were incubated for
30 min at room temperature with TRITC-labelled phalloidin to
stain F-actin or with the anti-p65-Rel antibody (dilution: 1:50)
followed by TRITC-labeled secondary antibody. After mounting
in PBS/glycerol (1:1, vol/vol), slides were analyzed with an
Olympus BX51 fluorescence microscope.
For IL-8 chemokine production, incubation medium of
variously transfected AGS cells was harvested 24 h after
transfection as described by Kim et al. [64]. Samples were diluted
10 folds in culture medium and aliquots of 100 ml were assayed for
IL-8 using the Flexia IL-8 ELISA kit (Biosource) as previously
described [65]. In each experiment, transfections were made in
triplicate and IL-8 assays in quadruplicate.
For Bcl2/Bcl-xL/Mcl1 expression analysis, after 24 h of
incubation, variously transfected AGS cells were recovered in
20 mM Tris-HCl buffer (pH 7.4) containing 10 mM EDTA,
137 mM NaCl, 2 mM Na3VO4, 100 mM NaF and a protease
inhibitor cocktail (Complete EDTA-free, Roche). Thirty mgo f
total proteins were separated by SDS-PAGE, transferred to a
PVDF membrane and incubated with the indicated antibodies.
Anti-mouse or anti-rabbit HRP-conjugated secondary antibodies
were then added and chemiluminescence was detected by using
the FUJIFILM Las-3000 apparatus. The same membrane was re-
probed with anti-a-tubulin antibodies as a loading control. Signal
quantification was performed using the MultiGauge software, and
protein expression was normalized by that of a-tubulin.
Confocal microscopy analysis
Immunofluorescence studies and analysis by confocal micros-
copy were performed as previously described [29,30,32] using a
confocal laser scanning microscope (TCS SP2, from Leica,
Heidelberg, Germany, or LSM510 Meta, from Carl Zeiss
MicroImaging, Jena, Germany) equipped with 636and 406oil-
immersion objectives. Briefly, variously transfected and treated
cells grown on coverslip were fixed with 4% paraformaldehyde,
permeabilized with 0.1% Saponin (Sigma-Aldrich) and processed
for immunofluorescence. The images were combined and merged
using Paint Shop Pro software (Corel, Ottawa, Canada).
Quantitative evaluation (percentage) of cells showing the ‘‘hum-
mingbird phenotype’’ under different transfection conditions was
carried out by extensive evaluation of slides from 3 independent
experiments. We defined a hummingbird cell that with an
elongated phenotype characterized by thin needle-like protrusions
longer than 10 mm [40,44,45]. For studying VacA endocytosis,
cells were incubated with 2 mg/ml acid-activated purified VacA
for 1 h at 4uC. After extensive washing, cells were incubated at
37uC in pre-warmed DMEM w/o FBS (for AGS cells) or Hanks’
balanced salt solution (HBSS; for MKN 28 cells) for 30 or 120 min
in the absence of ammonium chloride or, to allow vacuole
development, for 4 h in the presence of 5 mM ammonium
chloride. Cells were then processed for immunofluorescence
analysis. All the pictures shown represent single confocal sections.
When the effect of the SKF inhibitor PP2 on VacA internalization
and intracellular trafficking was investigated, cells were preincu-
bated with 10 mM PP2 at 37uC for 30 min before being exposed to
VacA as described above, and the drug was maintained
throughout the experiments. To investigate VacA internalization
and intracellular trafficking in each transfection condition, by
means of extensive confocal microscopy analysis of slides from at
least 3 different experiments we calculated the percentage of either
cells exhibiting cytoplasmic vacuoles (a widely accepted functional
readout for the presence of VacA in the late endosomal
compartment) or cells exhibiting the VacA-associated fluorescence
strictly limited at the cell periphery (i.e., likely in the GEECs only)
or, on the contrary, in the perinuclear area (i.e., cells deeply
internalizing VacA). In addition, by means of colocalization and
cell counter plugins of ImageJ software (National Institutes of
Health, Bethesda, MD), in some experiments VacA intracellular
trafficking to LEs was evaluated by calculating, in variously treated
or control cells, the percentage of LAMP1-positive vesicles (i.e.,
LEs) containing VacA. When the effect of CD treatment on VacA
trafficking to mitochondria and on toxin-induced alteration of
mitochondrial morphology, DsRed-Mito-transfected AGS cells
were incubated with 2 mg/ml activated Cy5-VacA for 1 h at 4uC.
After washing, cells were allowed to internalize the toxin into
GEECs by incubation for 15 min at 37uC in DMEM w/o FBS
(and without ammonium chloride supplementation), then CD
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for 3 h. After fixation, cells were observed at the confocal
microscope. To investigate the effect of CD treatment on VacA-
induced MTP drop, MKN 28 cells grown on glass-bottomed
dishes were incubated with VacA (2 mg/ml) for 15 min at 37uCt o
allow toxin entry into GEECs, washed and incubated for further
105 min with HBSS (without ammonium chloride supplementa-
tion) in the absence or presence of CD (0.5 mg/ml). Relative MTP
was then measured by using the ratiometric potential-sensitive dye
JC-1 (5,59,6,69-tetrachloro-1,19,3,39-tetraethylbenzimidazolylcar-
bocyanine iodide; from Molecular Probes). Indeed, this cationic
lipid exhibits potential-dependent accumulation in mitochondria,
indicated by a fluorescence emission shift from green to red [66].
Mitochondrial depolarization is indicated by a decrease in the
red/green fluorescence intensity ratio which depends only on
MTP and not on other factors such as mitochondrial size, shape
and density. JC-1 (6 mM) was added to the cells during the last
15 min of incubation and, after washing, cells were immediately
analyzed at the confocal microscope. In each experiment, the red/
green fluorescence intensity ratio was calculated for at least 100
cells for each experimental condition by using the Leica software.
Apoptosis assays
To study the apoptosis degree induced by either VacA or
etoposide on variously transfected gastric epithelial cells, AGS cells
grown in Petri dishes were treated with either 5 mg/ml acid-
activated purified VacA for 18 h or 300 mM etoposide for 6 h in
DMEM w/o FBS, while MKN 28 cells were treated with the
aforementioned amounts of VacA or etoposide in HBSS for 18 h
or 24 h, respectively. No supplementation of incubation medium
with ammonium chloride was made. When the effect of CD
treatment on VacA-induced apoptosis was investigated, MKN 28
cells were incubated with VacA (2 mg/ml) for 15 min at 37uCt o
allow toxin entry into GEECs, washed and incubated for further
18 h with HBSS in the absence or presence of CD (0.5 mg/ml).
Then the incubation medium was collected and the adherent cells
were splitted by means of TrypLE Express (Invitrogen) and added
to the corresponding incubation medium. After centrifugation at
150 g for 5 min, the cell pellet was resuspended in 100 mlo f
binding buffer (10 mM Hepes, 140 mM NaCl, 2.5 mM CaCl2,
pH 7.4) containing RPE-annexin V and incubated at room
temperature for 15 min. Counting of the percentage of apoptotic
(i.e., annexin V-positive) cells for each experimental condition was
then carried out using a wide-field fluorescence microscope
equipped with the proper filter sets. The percentages of apoptotic
cells were shown as fold increase over the respective non-
transfected control cells.
To study the apoptosis degree of gastric epithelial cells infected
with wild-type CagA
+/VacA
+ H. pylori strains or their isogenic
mutants lacking CagA or VacA, cells grown on Petri dishes were
infected with the different H. pylori strains at a multiplicity of
infection of 100 bacteria per cell and incubated in HBSS (for
MKN 28 cells) or DMEM w/o FBS (for AGS cells) for 18 h at
37uC in the absence or presence of 5 mg/ml acid-activated purified
dominant-negative VacA D6-27 cytotoxin added immediately
before the bacteria. No supplementation of incubation medium
with ammonium chloride was made. After the incubation period,
cells were harvested and stained using the annexin V-FLUOS kit
(Roche Diagnostics) as described by Mimuro et al. [18]. Flow
cytometric analysis was then performed using a FACSCalibur flow
cytometer and CellQuest software (BD Biosciences). The percent-
ages of apoptotic cells were shown as fold increase over the
respective non-infected control cells.
Statistics
Results were expressed as mean6SEM of three independent
experiments. The statistical significance of the differences was
evaluated by unpaired Student’s t-test or by analysis of variance
(ANOVA) followed by Newman-Keuls’ Q-test; significance was set
at P,0.05. Data expressed as a percentage of control were
analyzed before being normalized versus control.
Supporting Information
Figure S1 Construction and expression into gastric epithelial cells
of the GFP-CagA C-ter fusion proteins. (A) Schematic representa-
tion of the GFP-CagA C-ter fusion proteins. (B) GFP-CagA C-ter
constructs expressed in AGS cells. *: shown here with the wt form;
the mut one gave a virtually identical expression level and identical
results (not shown). The mock vector (GFP) served as a control.
Constructs in membrane (Mb) or cytosol (Cy) fractions or total cell
lysate (T) were analyzed by immunoblotting (IB) using anti-GFP or
anti-CagA antibodies. kDa: kilodalton. (C) AGS cells tranfected
with GFP-CagA C-ter, either wt or mut, were immunoprecipitated
(IP) for phosphotyrosines and blotted by anti-CagA.
Found at: doi:10.1371/journal.ppat.1000603.s001 (0.76 MB PDF)
Figure S2 Only transfection with GFP-CagA C-ter wt impairs
VacA arrival into late endosomes of gastric epithelial cells. (A and
B) VacA colocalization with the late endosomal marker LAMP1 in
AGS (A) or MKN 28 (B) cells transfected with GFP or GFP-CagA
C-ter, either wt or mut. After a VacA binding step of 1 h at 4uC,
cells were allowed to internalize the toxin for 120 min and then
were fixed. VacA (red) and LAMP1 (blue). Transfected cells
(green). All the pictures shown represent single confocal sections.
Scale bar: 10 mm. (C) Percentage of late endosomes (i.e., LAMP1-
positive vesicles) containing VacA in either AGS or MKN 28 cells
variously transfected and treated as above. Mean6SEM by
extensive confocal microscopy evaluation of slides from 3
independent experiments. *: P,0.05 versus non-transfected cells.
Found at: doi:10.1371/journal.ppat.1000603.s002 (1.44 MB PDF)
Figure S3 Transfection with GFP-CagA C-ter, either wt or mut,
does not alter expression of Bcl2, Bcl-xL, or Mcl1 in gastric
epithelial cells. Representative blot (left) showing expression of
Bcl2, Bcl-xL, and Mcl1 in AGS cells transfected with GFP or GFP-
CagA C-ter, either wt or mut. Histograms (right) represent the
amount of Bcl2, Bcl-xL, and Mcl1 (normalized for protein loading
(a-tubulin) and shown as percentage of GFP-transfected control
cells) for each transfection condition. Mean6SEM of 3 indepen-
dent experiments. No statistically significant difference was found.
Found at: doi:10.1371/journal.ppat.1000603.s003 (0.69 MB PDF)
Figure S4 Further evidence that CagA antagonizes VacA-
induced apoptosis in H. pylori-infected gastric epithelial cells.
Apoptosis degree (shown as fold increase over the respective non-
infected control cells) of AGS or MKN 28 cells infected with the
wild-type CagA
+/VacA
+ H. pylori strain G27 (WT) or its isogenic
mutant lacking CagA (DcagA). Mean6SEM of 3 independent
experiments. *: P,0.05 versus control. u: P,0.05 versus WT.
Found at: doi:10.1371/journal.ppat.1000603.s004 (0.63 MB PDF)
Table S1 Primers for the construction of the fusion proteins
used, and for site-directed mutagenesis of tyrosine residues of the
EPIYA motifs into glycine.
Found at: doi:10.1371/journal.ppat.1000603.s005 (0.05 MB PDF)
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